Search
for
Sort by
Research 721–750 of 913
- Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
- Androgen sensitivity gateway to COVID‐19 disease severity
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Oxidative Stress–Associated Senescence in Dermal Papilla Cells of Men with Androgenetic Alopecia
- Visualising Androgen Receptor Activity in Male and Female Mice
- Extracellular vesicles as human therapeutics: A scoping review of the literature
- Estrogen Receptor α, but not Estrogen Receptor β, is Involved in the Regulation of the Hair Follicle Cycling as well as the Thickness of Epidermis in Male Mice
- Organoid technology for tissue engineering
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- 3α-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats
- Male sex hormones, aging, and inflammation
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Targeting integrin pathways: mechanisms and advances in therapy
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- PROTACs: A novel strategy for cancer drug discovery and development
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Evaluation of Sexual Function With an International Index of Erectile Function in Subjects Taking Finasteride for Androgenetic Alopecia
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-α